LBF20207PG45: Difference between revisions
m (LBF20307PG31 moved to LBF20207PG45) |
No edit summary |
||
Line 5: | Line 5: | ||
|LipidMaps=- | |LipidMaps=- | ||
|SysName=9a,11a,15R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |SysName=9a,11a,15R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | ||
|Common Name=&&15 (R) -Prostaglandin | |Common Name=&&15 (R) -Prostaglandin F_2alpha&& | ||
}} | }} |
Revision as of 07:35, 19 December 2008
IDs and Links | |
---|---|
LipidBank | XPR1787 |
LipidMaps | - |
CAS | |
KEGG | {{{KEGG}}} |
KNApSAcK | {{{KNApSAcK}}} |
mol | LBF20207PG45 |
15 (R) -Prostaglandin F_2α | |
---|---|
Structural Information | |
9a,11a,15R-trihydroxy-prosta-5Z,13E-dien-1-oic acid | |
| |
Formula | C20H34O5 |
Exact Mass | 354.240624198 |
Average Mass | 354.48096000000004 |
SMILES | C(CC[C@@H](O)C=C[C@H]([C@H]1CC=CCCCC(O)=O)[C@@H](C[C@@H]1O)O)CC |
Physicochemical Information | |
Spectral Information | |
Mass Spectra | |
UV Spectra | |
IR Spectra | |
NMR Spectra | |
Other Spectra | |
Chromatograms |
Reported Metabolites, References | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
|